Project Number Colnaghi-2018 Agency/Funding Organization The Association for Frontotemporal Degeneration|Alzheimer's Drug Discovery Foundation Funding Year 2018 View Full Project Details for SUMO2 mimetics as innovative inhibitors of tau toxicity in pre-clinical models of frontotemporal dementia Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Colnaghi, Luca Principal Investigator First Name Luca Principal Investigator Last Name Colnaghi Awardee Organization Plico Biotech Awardee State New York, N.Y. Contact PI Country United States Project Detail FY Overall Cost $148,000 Funding Organization Agency/Funding Organization The Association for Frontotemporal Degeneration|Alzheimer's Drug Discovery Foundation Program Official Nadine Tatton (AFTD)/Lauren Friedman (ADDF)
